Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry
Author(s) -
Manasi Agrawal,
Erica J. Brenner,
Xian Zhang,
Irene Modesto,
John Woolcott,
Ryan C. Ungaro,
JeanFrédéric Colombel,
Michael D. Kappelman
Publication year - 2020
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/d116-2406
Subject(s) - tofacitinib , covid-19 , medicine , virology , rheumatoid arthritis , disease , outbreak , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom